Cooking the Books podcast: Why weight-loss drug Ozempic is getting Wall St attention

Weight-loss drugs are amongst the trends that fund managers are watching, and expecting to make money. Photo / 123RF

Each week BusinessDesk and the NZ Herald’s Cooking the Books podcast tackles a different money problem. Today, it’s the trends fund managers are watching, and banking on. Hosted by Frances Cook.

They say that change is the only constant, which is particularly true in the investing world.

One moment there’s a hot stock rocketing in price, the next minute, the company is down again, and it’s on to the next.

To invest well amongst all the noise means the ability to step back, take the long view, and decide what’s actually a trend that’s likely to last, and keep that business making money.

That’s exactly what fund managers do, and there are some spicy choices that have caught their attention recently, including weight loss drugs like Ozempic, and the change towards renewable electricity.

So what are they watching, and should you be doing the same?

For the latest podcast, I talked to Nathan Field, global equities portfolio manager for Generate.

For the interview, listen to the podcast here.

• If you have a question about this podcast, or a question you'd like answered in the next one, come and talk to me about it. I'm on Facebook here, Instagram here, and Twitter here.

• Listen to the full interview on the Cooking the Books podcast. You can subscribe on iHeartRadio, Apple Podcasts, or Spotify.